Palladium Pd-103 Uses, Dosage, Side Effects and more
Palladium Pd-103 is under investigation in clinical trial NCT00247312 (Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial).
| Trade Name | Palladium Pd-103 |
| Generic | Palladium Pd-103 |
| Type | |
| Formula | Pd |
| Weight | Average: 102.9061 Monoisotopic: 102.906087204 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
